Compare FITB & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FITB | DXCM |
|---|---|---|
| Founded | 1858 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 31.7B |
| IPO Year | N/A | 2005 |
| Metric | FITB | DXCM |
|---|---|---|
| Price | $45.82 | $65.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 21 |
| Target Price | $49.94 | ★ $87.81 |
| AVG Volume (30 Days) | ★ 6.0M | 5.9M |
| Earning Date | 01-20-2026 | 10-30-2025 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ 11.70 | 7.75 |
| EPS | ★ 3.35 | 1.80 |
| Revenue | ★ $8,125,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $15.95 | $17.41 |
| Revenue Next Year | $30.41 | $12.78 |
| P/E Ratio | ★ $13.55 | $36.45 |
| Revenue Growth | 0.77 | ★ 14.21 |
| 52 Week Low | $32.25 | $54.11 |
| 52 Week High | $47.86 | $93.25 |
| Indicator | FITB | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 69.67 | 60.15 |
| Support Level | $40.68 | $61.08 |
| Resistance Level | $44.15 | $65.32 |
| Average True Range (ATR) | 0.92 | 1.88 |
| MACD | 0.38 | 0.92 |
| Stochastic Oscillator | 87.75 | 86.86 |
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.